We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improper Anticoagulant Therapy Increases Bleeding Risk

By HospiMedica International staff writers
Posted on 12 Mar 2019
A new study reveals that many patients receiving warfarin for the management of atrial fibrillation (AF) or venous thromboembolism (VTE) also take aspirin without a clear therapeutic indication.

Researchers at the University of Michigan (U-M; Ann Arbor, USA), Huron Valley Sinai Hospital (Commerce Township, MI, USA), and other institutions conducted a registry-based cohort study involving 6,539 adults (50.9% men) at six anticoagulation clinics in the state of Michigan receiving warfarin therapy for AF or VTE (without documentation of a recent myocardial infarction or history of valve replacement), in order to evaluate the frequency and outcomes of combination anticoagulation therapy without clear indication.

Of the study cohort, 2,453 patients (37.5%) who had no clear therapeutic indication for aspirin were receiving a combination warfarin and aspirin therapy. More...
Of these, 5.7% experienced major bleeding events after one year, compared to 3.3% of those on warfarin only. The combination therapy group was also hospitalized for bleeding significantly more often. However, there was no difference in stroke or heart attack outcomes at one year, and mortality rates were similar between both groups, at 2.3%. The study was published on March 4, 2019, in JAMA Internal Medicine.

“Nearly 2,500 patients who were prescribed warfarin were taking aspirin without any clear reason, over a seven-year period. No doctors really own the prescribing of aspirin, so it's possible it got overlooked,” said senior author vascular cardiologist Geoffrey Barnes, MD, MSc, of the U-M Medical School. “The combination does make sense for a small number of people; patients who may need to be on both medications include those who have had a recent heart attack, recent coronary stent placement, or bypass surgery, prior mechanical valve surgery, or known peripheral artery disease.”

“Clinicians should ask their patients who are anticoagulated with warfarin if they're taking aspirin as well. For the patients who are on both therapies, clinicians should review their medical history to determine if it's really necessary to be on both drugs,” said lead author hematologist Jordan Schaefer, MD, of M-U Medicine. “There's been some hint of this being an issue for a long time. Now, based on these new findings, we're working to reduce the number of patients on aspirin without a clear reason for both drugs.”

Aspirin (acetylsalicylic acid) is a salicylate drug often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin's efficacy as an anticlotting agent and its widespread use as a preventive treatment for heart attacks and strokes have turned it into one of the most widely used medications in the world, with an estimated 40,000 tons of it being consumed each year.

Related Links:
University of Michigan
Huron Valley Sinai Hospital


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.